AUDENTES THERAPEUTICS INC's ticker is BOLD and the CUSIP is 05070R104.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $25,234,000 | +11.0% | 660,406 | -12.7% | 0.66% | +4.1% |
| Q1 2018 | $22,724,000 | -6.9% | 756,215 | -3.2% | 0.64% | -21.4% |
| Q4 2017 | $24,416,000 | -44.2% | 781,309 | -50.0% | 0.81% | -3.2% |
| Q3 2017 | $43,770,000 | +223.4% | 1,562,618 | +120.9% | 0.84% | +22.8% |
| Q2 2017 | $13,534,000 | +10473.4% | 707,500 | +9333.3% | 0.68% | +9628.6% |
| Q1 2017 | $128,000 | -6.6% | 7,500 | 0.0% | 0.01% | -30.0% |
| Q4 2016 | $137,000 | +2.2% | 7,500 | 0.0% | 0.01% | +11.1% |
| Q3 2016 | $134,000 | – | 7,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEXTHERA CAPITAL LP | 250,620 | $9,779,000 | 11.87% |
| Versant Venture Management, LLC | 803,106 | $31,337,196,000 | 10.32% |
| GREAT POINT PARTNERS LLC | 1,572,618 | $61,364,000 | 6.07% |
| Casdin Capital, LLC | 1,010,000 | $39,410,000 | 4.33% |
| Sofinnova Investments, Inc. | 933,640 | $36,431,000 | 3.51% |
| Foresite Capital Management III, LLC | 315,331 | $12,304,000 | 3.20% |
| Redmile Group, LLC | 2,735,267 | $106,730,000 | 3.12% |
| Opaleye Management Inc. | 280,000 | $10,926,000 | 3.02% |
| Global Endowment Management, LP | 391,581 | $15,279,000 | 2.16% |
| Ghost Tree Capital, LLC | 175,000 | $6,829,000 | 1.78% |